New CRISPR based gene-editing treatment targets root cause of kidney disease
A single-dose gene-editing therapy has shown it can correct the genetic cause of autosomal dominant polycystic kidney disease in preclinical...
A single-dose gene-editing therapy has shown it can correct the genetic cause of autosomal dominant polycystic kidney disease in preclinical...
Chronic kidney disease (CKD) is on the rise in the United States, with roughly 36 million adults estimated to have...
Home / News / Clinical trial targets kidney cancer with internal radiation Media Release October 2, 2025 Media Release October...
Alberta conducted five new immigration draws in February under the Alberta Advantage Immigration Program (AAIP). February 19 & 18: The...
Open this photo in gallery:Martin Lagman, who receives treatment for kidney disease at one of SHN’s satellite dialysis units three...
WASHINGTON -- A California biotechnology company that helps doctors detect genetic causes for cancer is among those that could be...